BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 10166764)

  • 1. "Agenda for Change" ends, enter ORYX.
    QRC Advis; 1997 May; 13(7):8, 7. PubMed ID: 10166764
    [No Abstract]   [Full Text] [Related]  

  • 2. Update on ORYX: the next evolution in accreditation.
    Jt Comm Perspect; 1997; 17(5):15-30. PubMed ID: 10182300
    [No Abstract]   [Full Text] [Related]  

  • 3. Special report--ORYX: the next evolution in accreditation. Joint Commission introduces new requirements to integrate performance measurement into accreditation process.
    Jt Comm Perspect; 1997; 17(1):26-7, 29. PubMed ID: 10346346
    [No Abstract]   [Full Text] [Related]  

  • 4. ORYX: how will it affect you?
    Hosp Peer Rev; 1997 Apr; 22(4):41-7. PubMed ID: 10166111
    [No Abstract]   [Full Text] [Related]  

  • 5. Redesigned ORYX Performance Measure Reports updated four times a year.
    Jt Comm Perspect; 2006 Mar; 26(3):9-12. PubMed ID: 16933569
    [No Abstract]   [Full Text] [Related]  

  • 6. JCAHO update. ORYX moves full speed ahead.
    Health Care Food Nutr Focus; 2000 Apr; 16(8):10-2. PubMed ID: 10977709
    [No Abstract]   [Full Text] [Related]  

  • 7. Should you consider ISO 9000?
    Hosp Peer Rev; 1998 Jan; 23(1):1-6. PubMed ID: 10175807
    [No Abstract]   [Full Text] [Related]  

  • 8. Showing improvement is a must for 1999 survey.
    OR Manager; 1998 Dec; 14(12):1, 10. PubMed ID: 10187725
    [No Abstract]   [Full Text] [Related]  

  • 9. The Joint Commission's agenda for change.
    Ente BH
    Curr Concepts Hosp Pharm Manage; 1989; 11(2):6-14. PubMed ID: 10293152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The next evolution in accreditation.
    O'Leary DS
    Jt Comm Perspect; 1996; 16(5):2-3. PubMed ID: 10166297
    [No Abstract]   [Full Text] [Related]  

  • 11. An assessment of accreditation with contingencies and the three-year award cycle.
    Ente BH
    QRB Qual Rev Bull; 1985 Mar; 11(3):93-6. PubMed ID: 3921895
    [No Abstract]   [Full Text] [Related]  

  • 12. Ready to answer ORYX data questions? Here's what Joint Commission will ask.
    ED Manag; 2000 Apr; 12(4):37-42. PubMed ID: 11067330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Change in the process for organizations in which their survey reports meet a rule for conditional accreditation or preliminary denial of accreditation decision.
    Jt Comm Perspect; 2004 Sep; 24(9):7. PubMed ID: 15484653
    [No Abstract]   [Full Text] [Related]  

  • 14. ORYX: the next evolution in accreditation.
    Bender N
    Ambul Outreach; 1998; ():23-4. PubMed ID: 10346585
    [No Abstract]   [Full Text] [Related]  

  • 15. Gearing up for the new accreditation process. Revised Joint Commission standards for 2004.
    Health Care Food Nutr Focus; 2003 Mar; 20(3):1, 3. PubMed ID: 12621703
    [No Abstract]   [Full Text] [Related]  

  • 16. The ORYX initiative: goals and potential application to physician quality improvement efforts.
    Hanold LS; Koss RG; Loeb JM
    Tex Med; 2000 Oct; 96(10):84-7. PubMed ID: 11070741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Joint Commission launches Standards Improvement Initiative.
    Jt Comm Perspect; 2006 Oct; 26(10):1. PubMed ID: 17139923
    [No Abstract]   [Full Text] [Related]  

  • 18. JCAHO to study closures.
    Burda D
    Mod Healthc; 1989 Sep; 19(38):6. PubMed ID: 10294772
    [No Abstract]   [Full Text] [Related]  

  • 19. The Joint Commission's "Agenda for Change".
    O'Leary DS
    J Med Assoc Ga; 1987 Jul; 76(7):503-7. PubMed ID: 3476682
    [No Abstract]   [Full Text] [Related]  

  • 20. Evidence helps organizations meet JCAHO leadership.
    Dahl M
    Health Care Food Nutr Focus; 2001 Jul; 17(11):8-10. PubMed ID: 11447897
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.